PRME•benzinga•
Chardan Capital Maintains Buy on Prime Medicine, Raises Price Target to $16
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 20, 2025 by benzinga